http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106591313-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-16
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57449
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1048
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2016-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106591313-B
titleOfInvention The aptamer WYZ-1 and its screening technique of ovarian mucinous cancer cell 3AO and application
abstract The present invention relates to the aptamer WYZ-1 of ovarian mucinous cancer cell 3AO a kind of and its screening technique and applications, the sequence of the aptamer WYZ-1 are as follows: 5 '-AGCTGCTATACTAGCTAAAGCCTTAGCTAGCTCAATAACGCGATATAGCATGCGCG ATGCCCGTAGCGATAGCTAGCTT-3 ', its screening technique are as follows: be based on SELEX screening technique, using ovarian serous cancer cell SKOV3 and normal ovarian epithelial cell IOSE as counter-selection cell, it is positive sieve cell with ovarian mucinous cancer cell 3AO, filter out the aptamer with ovarian mucinous cancer cell 3AO specific binding, it has high specific, high-affinity, it can body Outer synthesis and modification, the features such as chemical property is stable, pharmacokinetic property is good, non-immunogenicity.
priorityDate 2016-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414861628
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507055
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552964
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322164
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7327
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18657672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426818776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496482

Total number of triples: 27.